Similar articles

• N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes.

  Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP, Mannucci PM, Mininni N, Prando MD, Tubaro M, Vernocchi A, Vecchio C; Italian Working Group on Atherosclerosis, Thrombosis, and Vascular Biology and the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO). Galvani M, et al. Circulation. 2004 Jul 13;110(2):128-34. doi: 10.1161/01.CIR.0000134480.06723.D8. Epub 2004 Jun 14. Circulation. 2004. PMID: 15197143
• Long reach of the N-terminal of B-type natriuretic peptide.

  SoRelle R. SoRelle R. Circulation. 2002 Dec 3;106(23):e9059. Circulation. 2002. PMID: 12460860 No abstract available.
• Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.

  Rothenbacher D, Koenig W, Brenner H. Rothenbacher D, et al. Arch Intern Med. 2006 Dec 11-25;166(22):2455-60. doi: 10.1001/archinte.166.22.2455. Arch Intern Med. 2006. PMID: 17159010
• Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.

  Palazzuoli A, Iovine F, Gallotta M, Nuti R. Palazzuoli A, et al. Minerva Cardioangiol. 2007 Aug;55(4):491-6. Minerva Cardioangiol. 2007. PMID: 17653025 Review.
• Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.

  de Lemos JA, Morrow DA. de Lemos JA, et al. Rev Cardiovasc Med. 2003;4 Suppl 4:S37-46. Rev Cardiovasc Med. 2003. PMID: 14564227 Review.